Although tanshinone IIA and cryptotanshinone exerted anti-CML activities in a different way by targeting the distinct STAT signaling, there was no significant difference in the induction of apoptosis by them. This evidence concerns the gene SOAT1 and chronic myelogenous leukemia, BCR-ABL1 positive.